Italy authorizes Hynica, an empagliflozin tablet, for sale
Italy's medicines agency AIFA has approved the sale of Hynica, a tablet containing empagliflozin, through a decision signed 23 October 2026 and published 6 November 2026. The license holder is Farmitalia Industria Chimico Farmaceutica S.r.l. of Rome. The tablets come in 10 mg and 25 mg strengths in several pack sizes, and can only be obtained with a doctor's prescription.
This summary was generated by AI; the official source prevails.
What does it mean?
Hynica is a new tablet for people who need empagliflozin, and it can now be sold in Italy. Because it needs a prescription, you will have to get it from a doctor, and it is not covered by the state reimbursement scheme.
Who is affected?
Patients who have been prescribed empagliflozin, and pharmacies and doctors who handle prescription medicines in Italy.